# Narcolepsy

This is a subcategory of Central Nervous System (CNS) Agents.

## Decision Trees

- [Narcolepsy - Sunosi, Wakix, Xyrem](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?auth_pvr=OrgId&auth_upn=anttwaniqua.greer%40gainwelltechnologies.com&origin=OfficeDotCom&lang=en-US&sessionid=dba554c2-2c78-4f60-bee3-f837172c2546&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUQU5UQUpSTExZNDVYNFJRRElJR1NTMzExWSQlQCN0PWcu&topview=Preview)
- [Narcolepsy - Xywav](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?auth_pvr=OrgId&auth_upn=anttwaniqua.greer%40gainwelltechnologies.com&origin=OfficeDotCom&lang=en-US&sessionid=dba554c2-2c78-4f60-bee3-f837172c2546&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNEo1WlROV0JLVFE1S0pUTTQ1UDdOSTBVMCQlQCN0PWcu&topview=Preview)

## Formulary

### Preferred

| Preferred                                            | Generic Name                                                | Quantity | Time (Days) |
| :--------------------------------------------------- | :---------------------------------------------------------- | :------: | :---------: |
| Amphetamine / Dextroamphetamine IR, ER <sup>AR</sup> |                                                             |          |             |
| Armodafinil                                          |                                                             |          |             |
| Dextroamphetamine ER <sup>AR</sup>                   | Dextroamphetamine Sulfate ER Cap (all strengths excl 15 MG) |    34    |     34      |
| Dextroamphetamine ER <sup>AR</sup>                   | Dextroamphetamine Sulfate ER Cap 15 MG                      |   136    |     34      |
| Methylphenidate ER <sup>AR</sup>                     |                                                             |          |             |
| Methylphenidate Tab <sup>AR</sup>                    | Methylphenidate HCI Tab (all strengths)                     |   102    |     34      |
| Modafinil                                            |                                                             |          |             |

### Non-Preferred

| Non-Preferred | Generic Name | Quantity | Time (Days) |
| :------------ | :----------- | :------: | :---------: |
| Sunosi        |              |          |             |
| Wakix         |              |          |             |
| Xyrem         |              |          |             |
| Xywav         |              |          |             |

## Authorizations

**Length of Authorizations**: 365 Days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **30 days** with at least **two preferred** drug
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Oxybate Salts (Xywav)

Additional Oxybate Salts (Xywav) Criteria

- Must have documented adherence to sodium restricted diet

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

**AR** - Adderall IR; a PA is required for patients younger than 3 years

**AR** - Adderall XR, Dexedrine ER: a PA is required for patients younger than 6 years

**AR** - Methylphenidate: a PA is required for patients younger than 6 years

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL%20_Criteria_APPROVED.pdf#page=42)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL_APPROVED_12.13.22.pdf#page=17)

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf)
